Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 64 citing articles:

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
Behavioural Brain Research (2014) Vol. 277, pp. 99-120
Open Access | Times Cited: 265
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 204
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, et al.
Neuropharmacology (2020) Vol. 167, pp. 107933-107933
Open Access | Times Cited: 187
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders
Giuseppe Di Giovanni, Philippe De Deurwaerdère
Pharmacology & Therapeutics (2015) Vol. 157, pp. 125-162
Closed Access | Times Cited: 103
“Selective” serotonin 5-HT2A receptor antagonists
Austen B. Casey, Meng Cui, Raymond G. Booth, et al.
Biochemical Pharmacology (2022) Vol. 200, pp. 115028-115028
Open Access | Times Cited: 53
Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response
I. Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113612-113612
Open Access | Times Cited: 51
1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review
Richard A. Glennon, Małgorzata Dukat
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1722-1745
Open Access | Times Cited: 10
Effect of Hallucinogens on Unconditioned Behavior
Adam L. Halberstadt, Mark A. Geyer
Current topics in behavioral neurosciences (2016), pp. 159-199
Open Access | Times Cited: 80
Therapeutic Potential of 5-HT2CReceptor Agonists for Addictive Disorders
Guy A. Higgins, Paul Fletcher
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 7, pp. 1071-1088
Closed Access | Times Cited: 77
Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
Guy A. Higgins, Paul Fletcher, William Shanahan
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107417-107417
Closed Access | Times Cited: 67
Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures
Marcello Venzi, François David, Joachim Bellet, et al.
Neuropharmacology (2016) Vol. 108, pp. 292-304
Open Access | Times Cited: 62
Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications
Orr Shahar, Alexander Botvinnik, Noam Esh-Zuntz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14148-14148
Open Access | Times Cited: 32
Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties ofN-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2AReceptor Agonist
Anders A. Jensen, John D. McCorvy, Sebastian Leth‐Petersen, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 361, Iss. 3, pp. 441-453
Open Access | Times Cited: 53
DARK Classics in Chemical Neuroscience: NBOMes
Christian B. M. Poulie, Anders A. Jensen, Adam L. Halberstadt, et al.
ACS Chemical Neuroscience (2019) Vol. 11, Iss. 23, pp. 3860-3869
Open Access | Times Cited: 53
Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System
Latham H. Fink, Noelle C. Anastasio, Robert G. Fox, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 8, pp. 1957-1968
Open Access | Times Cited: 47
Merging the Pathophysiology and Pharmacotherapy of Tics.
Farhan Augustine, Harvey S. Singer
DOAJ (DOAJ: Directory of Open Access Journals) (2018) Vol. 8, pp. 595-595
Closed Access | Times Cited: 39
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review
I. Erkizia-Santamaría, Igor Horrillo, J. Javier Meana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111249-111249
Closed Access
The psychedelic (−)-2,5-dimethoxy-4-iodoamphetamine [(−)-DOI] demonstrates efficacy in reducing cocaine reward and motivation in male rats
Leah M. Salinsky, Christina R. Merritt, Erik J. Garcia, et al.
Psychopharmacology (2025)
Open Access
Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice
Adam L. Halberstadt, Ivan S. Sindhunata, Kees Scheffers, et al.
Neuropharmacology (2016) Vol. 107, pp. 364-375
Open Access | Times Cited: 35
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Clinton E. Canal
Handbook of experimental pharmacology (2018), pp. 227-260
Open Access | Times Cited: 32
Evaluating bexicaserin for the treatment of Developmental Epileptic Encephalopathies
Giovanni Battista Dell’Isola, Alberto Verrotti, Miriam Sciaccaluga, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1121-1130
Closed Access | Times Cited: 3
Controversies Surrounding the Pathophysiology of Tics
Harvey S. Singer, Farhan Augustine
Journal of Child Neurology (2019) Vol. 34, Iss. 13, pp. 851-862
Closed Access | Times Cited: 29
5-HT 2 receptor affinity, docking studies and pharmacological evaluation of a series of 1,3-disubstituted thiourea derivatives
Anna Bielenica, Ewa Kędzierska, Michał Koliński, et al.
European Journal of Medicinal Chemistry (2016) Vol. 116, pp. 173-186
Closed Access | Times Cited: 25
Synthesis and Structure–Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT2 Receptor Agonist
Geoffrey B. Varty, Clinton E. Canal, Tina A. Mueller, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6144-6188
Closed Access | Times Cited: 2
A Novel Aminotetralin-Type Serotonin (5-HT)2CReceptor-Specific Agonist and 5-HT2ACompetitive Antagonist/5-HT2BInverse Agonist with Preclinical Efficacy for Psychoses
Clinton E. Canal, Drake Morgan, Daniel E. Felsing, et al.
Journal of Pharmacology and Experimental Therapeutics (2014) Vol. 349, Iss. 2, pp. 310-318
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top